Contact this trialFirst, we need to learn more about you.
Cromoglicate for Schizophrenia
Recruiting0 awardsPhase 1 & 2
Pittsburgh, Pennsylvania
This trial is testing whether cromoglicate can help treat schizophrenia when used in addition to other treatments. The trial is double blind, meaning neither the participants nor the researchers will know who is receiving cromoglicate or a placebo until the trial is over.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.